← Back to Search

Combined for Attention Deficit Hyperactivity Disorder (ADHD)

N/A
Waitlist Available
Led By Amori Y Mikami, PhD
Research Sponsored by University of Virginia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the first day of the treatment and the last day of the treatment (two weeks later)
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to help children with ADHD make friends by training teachers to highlight their positive behaviors. The goal is to reduce peer rejection by changing how classmates perceive these children. The intervention will be tested in a program similar to a regular classroom.

Eligible Conditions
  • Attention Deficit Hyperactivity Disorder (ADHD)

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the first day of the treatment and the last day of the treatment (two weeks later)
This trial's timeline: 3 weeks for screening, Varies for treatment, and the first day of the treatment and the last day of the treatment (two weeks later) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Child Peer Relationships
Secondary study objectives
Child Behavior Problems

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: CombinedExperimental Treatment2 Interventions
This represents a combination of the tolerance training and behavioral management interventions together.
Group II: Behavioral managementActive Control1 Intervention
This represents the behavioral contingency management intervention only.

Find a Location

Who is running the clinical trial?

University of VirginiaLead Sponsor
780 Previous Clinical Trials
1,315,448 Total Patients Enrolled
2 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
514 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Amori Y Mikami, PhDPrincipal InvestigatorUniversity of Virginia
~7 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top